The measurement of thoracic electrical bioimpedance (TEB) offers a continuous, non-invasive method for monitoring cardiac output (CO). For clinical use, agreement with a current standard should be demonstrated. We describe a modification to the manufacturer's suggested data entry into the NCCOM3-R6 TEB monitor (BoMed Medical Manufacturing), which results in improved agreement with indocyanine green dye dilution (DD) CO estimation in paediatric patients. The manufacturer's instructions for the NCCOM3-R6 include an estimation of the volume of electrically participating thoracic tissue (VEPT) based on body weight. We also estimated the VEPT from direct anatomical measurement of thoracic length and circumference. The mean difference between paired DD and TEB CO using the manufacturer's weightbased instructions was 0.6911min with 95% confidence limits 2.34 to -0.96 IImin. The mean difference between the two CO techniques using our calculated VEPTwas 0.35 IImin with 95% confidence limits 1.50 to -0.80 IImin. The linear regression correlation coefficient between the two techniques was 0.88 using VEPT estimated from the manufacturer's instructions and 0.94 using our calculated VEPT from measurement of thoracic dimensions. The range of DD CO was 0.41 to 8.35 IImin.
Non-invasive monitoring techniques have inherent advantages over invasive techniques in critically ill patients. The dye dilution (DD) and thermodilution (TO) methods of measuring cardiac output (CO) have become reference standards but each is troublesome to perform, presents considerable risks to the patient and offers only brief glimpses of the dynamic circulatory state.
The technique of estimating CO with measurement of TEB during the cardiac cycle is both continuous and non-invasive. Although TEB CO has been available since the 1960s, it had not been clinically accepted due to lack of agreement with invasive techniques. The availability of a new machine (BoMed NCCOM3) incorporating a revised stroke volume equation has renewed interest in the technique. Before the TEB technique can be substituted for invasive standard techniques for measuring CO, it should be evaluated in a variety of conditions and sUbjects.
The majority of the recent literature on the TEB method I of estimating CO compares it with TO in adults 2 -8 and animals. 9 -12 These studies generally show that at least 75% of simultaneous measurements are within ± 20% of each other.
More importantly there is reasonable agreement of trending. The technique has also been used in children. II , When TO was first introduced l8 the reference against which it was compared was DD. TO has become the standard method in most adult intensive care units, not because of any inherent superiority over DD in estimating CO, but because it is relatively simple, has reasonable reproducibility and the necessary pulmonary artery catheter also provides continuous pulmonary arterial pressures and may be wedged to provide an indirect estimate of left ventricular preload.
The indocyanine green DD method has been the so-called 'gold standard' in most paediatric units for a variety of reasons. These include historical factors, indicator dilution techniques being first described in the 1930s, and simplicity, with only central venous and arterial catheters being required. As well, the TD technique has not been practical in babies until the recent miniaturisation of pulmonary artery catheters.
We have used the NCCOM3-R6 TEB unit (BoMed Medical Manufacturing) and compared it with indocyanine green DD CO estimation in paediatric patients. We had previously observed a poor agreement between the techniques when the manufacturer's guidelines on the use of the NCCOM3-R6 in children were followed. According to these guidelines, a number (L) which is an index (based on weight) of the patient's thoracic dimensions is entered into the NCCOM3-R6. We reviewed the formulae upon which L is based in the hope of finding a more accurate method of its derivation and so improve agreement between the techniques.
THEORY
The theoretical basis of TEB is that the thorax acts as a conductor of electricity passed between electrodes placed at the root of the neck and at the level of the xiphisternum. This thoracic volume conductor has a base impedance, Zo ohms, with changes in impedance OZ (pulsatile Z) occurring with aortic flow. The plot of pulsatile Z with time resembles an arterial pressure wave form. Kubicek observed that the maximum rate of change of pulsatile Z, (¥-) max ohm/sec, is proportional to the peak flow of lblood in the ascending aorta 19 and devised the formula:
where, SV = stroke volume (rnl) p = resistivity of blood (ohm. cm) L = distance between the sensing electrodes (cm) T = left ventricular ejection time (sec).
(1)
Whereas Zo varies with ventilation and is the basis for impedance respiratory monitoring, (~)max is less sensitive to ventilation.
Quail et al. 20 had observed that p was virtually constant over a wide range of physiological disturbances and changes in haematocrit. Sramek 21 postulated that the thorax was a cylindrical conductor. He also noted that the term P(L 2/Z02) in equation (1) has the units mVohm and represents the ratio of electrically participating thoracic tissue (Veptt) to ZOo Using this, Sramek then rewrote Kubicek's equation (1) as: Veptt Sramek noted that the volume of the cylinder encompassing the thorax at the levels of the band of electrodes was:
Volumecylinder where, C = circumference L = length (3) but, by calculation and experimental confirmation, that the proportion (K) of the cylinder actually participating in conducting electricity was only approximately is of the cylinder. Hence the actual formula for the participating volume is: C2L
Conceptually, this proportion consists of a truncated cone ( Figure 1 ) with the same base as the cylinder, and with a small cylinder which constitutes the spinal column removed.
Hence the full Sramek equation is:
Sramek introduced less technical terms to describe equation (5): EVI
Veptt volume of electrically participating thoracic tissue (rnl) VET = T = ventricular ejection time (sec) EVI = (oZ/ot)max = ejection velocity index (ohm/sec) TFI = Zo = thoracic fluid index (ohm).
In an attempt to simplify equation (4), Sramek,22 using 30 radiographs and measurement of the rib cage noted that in all subjects, regardless of age or sex, C/L ratio is approximately equal to 3.0 (7) except in neonates whose C/L ratio averaged 2.6, and therefore: o VEPT = 4.25 and equation (4) (9) Note that Sramek has changed the factor, K, from is to to in this latest version of the equation.
When using the NCCOM3 TEB unit in children, L is read from a table of values based on patient weight (kg) provided by the manufacturer. For example, a patient with weight 12 kg and normal body form would have an L value of 15 cm, although the measured length of the thorax (i.e. the length of the truncated cone, Lm) might be 17 cm.
Since the value for L was cubed in Sramek's simplified equation (8) and hence any error in Lis cubed, we suspected that the source of the poor correlation between TEB and DD in our patients was in the L component of the equation for Sv. In the example of the 12 kg patient above, there is an almost 50% increase in the value for VEPT (and hence CO) between the two L values 15 and 17 cm.
To establish if the manufacturer's guidelines for L were the source of error, we measured the actual circumference (C) of the chest at the xiphisternum and the length of the truncated cone (Lm) and calculated VEPT using the earlier equation (4) . We then inserted this value into a rearranged equation (8) to calculate that L value (Lc) which the NCCOM3 would need entered to internally produce the 'correct' VEPT.
is:
Hence the value to enter into the NCCOM3 (Lc) VC2 * Lm Weights ranged from 3.6 to 43.7 kg with a mean of 13.9 kg. Eighteen patients (75%) were less than the 50th centile for weight and ten (42%) were less than the 10th centile for weight. Age ranged from 2 months to 15 years with 18 of the 24 children under the age of 3 years.
DD CO measurement is a routine method of assessing cardiac function in our two units, and no patient underwent more than the usual number of postoperative estimations for this study. Verbal consent was obtained from parents at the bedside. The study was approved by the hospitals' Ethics Committees.
NCCOM3 electrodes were applied according to the manufacturer's instructions with electrodes placed as in Figure 1 (current-injecting electrodes being 5 cm outside the sensing electrodes in the same coronal plane). Once the NCCOM3 was reliably displaying CO values, the injection of indocyanine green began. A measured mass and volume of freshly prepared green dye was rapidly injected into a central venous catheter. Blood was withdrawn simultaneously at a fixed rate by syringe pump from a peripheral arterial catheter and passed through a densitometer to record the indicator concentration. This was graphed simultaneously. It is our usual practice to average at least two DD estimations of CO.
TEB estimations of CO were obtained for two L values alternately entered into the unit:
(1) L, read from the manufacturer's table giving L values for various paediatric weight ranges; and, (2) L c , our calculated L value (from formula 10) to produce within the machine an appropriate estimation of VEPT based on measured thoracic dimensions. We then compared:
(1) the agreement between DD CO and TEB CO using the manufacturer's table of L values for weights; with, (2) the agreement between DD CO and TEB CO based on Lc.
RESULTS
The ratio of circumference (C) of the base of Sr~mek's truncated cone to the measured length of t~IS cone (Lm) was between 3.1 and 4.9 (Figure 2) , WIth an ave!a~e of 4.0. Hence Sramek's assumption that the ratio IS fixed at 3.0 and allows substitution of (3L)2 f~r C2 in equation (5) to give equation (9) is not. appbcable in our critically ill ventilated patIents. The agreement of DD with TEB using the two L values is graphically described in Figures 3 and 4 . The linear relationship between DD and TEB using the manufacturer's weight-based L value ( Figure 3 ) has a slope of only 0.60, but a Y intercept reasonably close to 0 (0.23), so that for higher CO in our patients, TEB grossly underestimates CO. Less than half the data points are within ± 20% of the line of identity. The correlation coefficient is 0.88. The linear relationship between DD and TEB using our calculated Lc (Figure 4 ) has a slope much closer to the line of identity, being 0.92, again with a Y intercept close to 0 ( -0.17). TEB CO estimations more closely match DD estimations over a wide range of CO. 71 % of data points are within ± 20% of the line of identity. The correlation coefficient is also slightly better at 0.94.
Using the F-test for difference between the slopes of the regression line in Figure 3 and that in Figure  4 , the Fs is 30.0. Comparing with Fu[I,44], the probability of the slopes not being different based on even this small number of data points is < om.
The statistical method of Bland and Altman 23 is used in Figures 5 and 6 . Figure 5 compares the DD method with TEB (using the manufacturer's suggested weight-based L value). There is a wide range of differences between measurements (standard deviation of differences 0.82 Umin) and the average difference between the two techniques is well above zero (0.69 Umin). Figure 6 compares the DD method with TEB (using our calculated Le> and shows that the range of differences between measurements is less (standard deviation of differences 0.58 Umin) and that the average difference between the two techniques is closer to 0 (0.35 Umin).
In a Customer Information Bulletin 24 the manufacturer suggests that the L value read from the supplied table be altered by 1 cm for each 20% of weight the child deviates from ideal weight for age. If this advice had been followed in our patients, an L value 1 cm less than that read from the table would have been used in eight patients. For any oZ/ot the entry of smaller L values causes the machine to read out lower cardiac outputs. As a result, the manufacturer's weight-based method would have resulted in an even worse underestimate of DD cardiac output in seven of those eight patients. In the other patient, although the agreement with DD would have been closer, it still would not have been as good as the agreement using our modification. Hence, following the manufacturer's advice regarding body weights outside the legal ideal weight for age ± 20% would appear to result in even worse agreement with DD. DISCUSSION We have shown that by using a modification to the manufacturer's guidelines for data entry into the NCCOM3 a better agreement with DD CO estimation in children is possible. It appears that the manufacturer's practice of using body weight alone to estimate the volume of electrically participating tissue results in increasing inaccuracy with increasing CO, and that the manufacturer's guidelines for adjusting for extremes of body weight for age worsens the agreement between TEB and DD CO estimation.
How best to combine the dimensions of the thorax in an equation which most accurately estimates VEPT is not yet clear. Bernstein 25 in adults and Belik and Pelech ll in neonates have described using a technique suggested by the manufacturer, whereby a length which is a percentage of body height is used as the L value. The technique in neonates ll is to calculate an L value which is an average of Lm (the measured length of the thorax) and 29% of the body length. The authors found there was a three-fold difference in observed CO between that using 29% of body length as the L value and that using Lm as the L value, whereas when the average of the two distances was used as the L value a CO was observed which most closely agreed with that predicted from animal data. Sramek 22 had described that in a large sample of individuals the mean thoracic length was 16.8% of the body height. In adults down to 40 kg weight, Bernstein 25 suggests the use of 17% of height as the L value, but only in patients at ideal body weight. He developed a nomogram relating weight to height for both sexes to allow for individuals deviating from the ideal body habitus.
More studies are necessary to establish the true relationships between weight, height, thoracic dimensions and the VEPT in children. Also, normal ranges need to be defined for these numbers in the critically ill paediatric population in which cardiac output estimation is most useful.
In practice the TEB method can be used either:
(1) as the sole method of measuring CO when patients lack invasive lines; or, (2) as a continuous readout of CO after the machine has been 'calibrated' against an invasive method as the standard. 15 We suggest that, ifTEB using the NCCOM-R6 in children is the sole method of monitoring CO, the thoracic circumference and length be measured by the operator and that our equation (10) be used to calculate the L value (Lc) to enter into the unit. Using this method, the agreement with DD CO estimation is reasonable and makes TEB CO monitoring clinically useful in paediatric intensive care. The agreement we and others 13 have found between TEB and DD estimations of CO is similar to the agreement among other methods -TD, Fick, Doppler and DD. 7,18,26.34 If the second technique of calibrating the TEB monitor against an invasive reference is used, as suggested by Introna et aI., 15 an empiric L value is entered into the NCCOM3-R6 until the TEB CO reading matches an invasive CO estimation (either DD or TD). Our preliminary experience suggests that this is a reliable method of continuously tracking CO, since we have found good agreement between the two methods at subsequent invasive estimations days later.
Wong et aP5 have shown that reproducible TEB CO measurement can be learned with less than two hours of formal training and an average of 8.4 ± 4.5 practice measurements in different subjects. The same degree of intraobserver variability as reported forTD (coefficientofvariance~ 10%) was achieved in 99% of triplicate measurements. The rate of learning the TEB method was faster than that for the suprasternal continuous-wave Doppler ultrasound method which required 12.9 ± 3.5
trials.
Difficulties we have encountered using TEB include failure of the machine to calculate oZ/ot when the heart rate exceeds approximately 190/min and crowding of the electrodes at the root of the neck in babies, especially when jugular venous lines are in place. Patients do need to be lying relatively motionless for a reliable readout to be continuously produced. We also found that it was often necessary to use an extra pair of electrodes placed in the line of the mean QRS vector for the NCCOM3-R6 to detect an R wave (which it uses to estimate heart rate). TEB is a relatively cheap and harmless method of continuously monitoring CO. Because of the difficulties of miniaturisation of catheter equipment and the well described risks of central venous and pulmonary artery catheterisation, a non-invasive method of measuring CO is particularly appealing in the paediatric population. We believe that with further refinements and a better understanding of how VEPT is related to measured thoracic dimensions, TEB will become a standard method of measuring CO in paediatric intensive care for patients without valvular regurgitation or intracardiac or aortopulmonary shunting.
